List of insiders holdings for ARTIVA BIOTHERAPEUTICS, INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 2026-05-13 17:47:40 | 16,377,468 0 | 16,377,468 | Form 13D |
| 2 | GC Corp. GC Cell Corp 10% Owner | 2026-05-28 16:38:12 | 5,999,703 0 | 5,999,703 | Form 13D |
| 3 | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 2024-08-01 16:17:22 | 2,353,304 0 | 2,353,304 | Form 13G |
| 4 | Huh Yong-Jun Director | 2024-07-22 20:22:03 | 0 1,810,945 | 1,810,945 | Form 4 |
| 5 | Aslan Fred Chief Executive Officer | 2026-05-19 21:50:02 | 1,535,082 0 | 1,535,082 | Form 4 |
| 6 | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S 10% Owner | 2025-05-15 16:44:26 | 1,198,975 0 | 1,198,975 | Form 13G |
| 7 | Bush Jennifer COO, CLO, Compliance Officer | 2026-05-19 21:51:19 | 337,920 0 | 337,920 | Form 4 |
| 8 | Miralles Gines Diego President & Head of R&D | 2026-05-19 08:11:07 | 310,000 0 | 310,000 | Form 4 |
| 9 | Horan Christopher Chief Tech Operations Officer | 2026-05-19 21:52:09 | 293,450 0 | 293,450 | Form 4 |
| 10 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 2024-07-22 20:28:17 | 243,127 0 | 243,127 | Form 4 |
| 11 | Huston Thad Allen Chief Financial Officer | 2026-03-10 16:47:06 | 220,000 0 | 220,000 | Form 4 |
| 12 | Raymon Heather SVP, Research and Development | 2026-05-19 21:52:54 | 148,228 0 | 148,228 | Form 4 |
| 13 | Banerjee Subhashis Chief Medical Officer | 2026-05-19 21:50:38 | 144,963 0 | 144,963 | Form 4 |
| 14 | Krishnamohan Neha Chief Financial Officer | 2025-11-17 20:38:17 | 99,356 0 | 99,356 | Form 4 |
| 15 | Graef Thorsten Chief Medical Officer | 2025-02-28 17:15:13 | 80,000 0 | 80,000 | Form 4 |
| 16 | Sorg Elaine K. Director | 2026-02-19 21:50:03 | 27,500 0 | 27,500 | Form 4 |
| 17 | Bessen Laura Director | 2024-07-18 20:02:02 | 17,098 0 | 17,098 | Form 3 |
| 18 | MOORE ALISON Director | 2025-06-26 16:30:22 | 13,750 0 | 13,750 | Form 4 |
| 19 | Baker Daniel G. Director | 2025-06-26 16:30:20 | 13,750 0 | 13,750 | Form 4 |
| 20 | HOUGEN ELIZABETH L Director | 2025-06-26 16:30:17 | 13,750 0 | 13,750 | Form 4 |
| 21 | Stoppel Laura Director | 2025-06-26 16:30:15 | 13,750 0 | 13,750 | Form 4 |
| 22 | DANIELS BRIAN Director | 2025-06-26 16:30:11 | 13,750 0 | 13,750 | Form 4 |